Expandable tip assembly for thrombus management
Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
1. An expandable tip assembly adapted to address an occlusive thrombus within a blood vessel without distal embolic protection, comprising:
a wire having a distal end;
an expandable and reconstrainable scaffold coupled to the distal end of the wire, the scaffold being adapted to radially self-expand from a non-expanded configuration to an expanded configuration upon unsheathing of the scaffold and to transition from the expanded configuration to the non-expanded configuration upon re-sheathing of the scaffold;
wherein the scaffold comprises a generally cylindrical configuration;
wherein the scaffold comprises a laser-cut tube;
wherein the scaffold comprises an open distal end without a distal embolic protection member or device;
wherein a proximal end of the scaffold comprises a cut-out section adapted to facilitate re-sheathing of the scaffold;
wherein the scaffold comprises a plurality of open cells defined by struts and connected by bridges;
wherein each strut has two ends, with each end connected to one of the bridges;
wherein the scaffold has a chronic outward force (COF) per unit length that does not decrease by more than 75% from an expansion diameter of 1.5 mm to an expansion diameter of 4.5 mm; and
wherein the open cells are sized to promote at least one of vessel reperfusion or thrombus removal.
2. The expandable tip assembly of claim 1 , wherein each bridge is connected to four struts.
3. The expandable tip assembly of claim 1 , wherein the scaffold is coupled to the distal end of the wire by a plurality of tether lines that extend eccentrically from one half of the distal end of the wire.
4. The expandable tip assembly of claim 1 , wherein the scaffold has a chronic outward force (COF) per unit length that does not decrease by more than 50% from a diameter of 1.5 mm to a diameter of 4.5 mm.
5. The expandable tip assembly of claim 1 , wherein the cells of the scaffold have a uniform cell size.
6. The expandable tip assembly of claim 1 , wherein the cells of the scaffold have a variable cell size.
7. The expandable tip assembly of claim 1 , wherein the strut thickness is substantially equal to the strut width.
8. The expandable tip assembly of claim 1 , wherein the expandable tip assembly comprises a reperfusion device and wherein the cells of the scaffold have a cell size adapted to inhibit protrusion of portions of the thrombus within an interior of the scaffold.
9. The expandable tip assembly of claim 1 , wherein the expandable tip assembly comprises a thrombus removal device, and wherein the cells of the scaffold have a cell size adapted to promote protrusion of portions of the thrombus within an interior of the scaffold.
10. The expandable tip assembly of claim 1 , wherein the cells of the scaffold have a cell length of between 4 mm and 6 mm and a cell height between 2 mm and 4 mm in the expanded configuration.
11. The expandable tip assembly of claim 1 , wherein the scaffold has an average chronic outward force across a diameter of 1.5 mm to 4.5 mm of between 0.0020 N and 0.0090 N.
12. The expandable tip assembly of claim 1 , wherein the struts comprise one or more surface features adapted to enhance engagement of thrombus material.
13. The expandable tip assembly of claim 12 , wherein the surface features comprise one or more grooves or one or more protrusions or projections.
14. The expandable tip assembly of claim 1 , wherein a central portion of each strut of the scaffold has a greater thickness than adjacent portions of the strut.
15. The expandable tip assembly of claim 1 , wherein the struts comprise multiple flex points along the length of the struts.
16. The expandable tip assembly of claim 1 , wherein the bridges form X-shaped connections between the cells of the scaffold.
17. The expandable tip assembly of claim 1 , wherein the bridges have a greater thickness than adjacent portions of the struts connected to the bridges.
18. The expandable tip assembly of claim 1 , wherein the scaffold is eccentrically coupled to the distal end of the wire with a plurality of tether lines.
19. The expandable tip assembly of claim 1 , wherein the scaffold is permanently, non-removably coupled to the wire.
20. The expandable tip assembly of claim 1 , wherein the scaffold is detachably coupled to the wire.
21. The expandable tip assembly of claim 1 , wherein the proximal end of the scaffold is open and/or tapered to facilitate resheathing into an outer catheter and increase blood flow through the scaffold.
22. The expandable tip assembly of claim 1 , wherein the scaffold has a maximum expansion diameter of about 1 mm to about 5 mm.
23. The expandable tip assembly of claim 1 , wherein the scaffold has a length of about from about 5 mm to about 50 mm.
24. The expandable tip assembly of claim 1 , wherein the scaffold comprises one or more of the following features:
a tapered body;
a coating configured to increase platelet activation or adhesion of the thrombus to the scaffold;
a length configured to at least partially span the thrombus;
sufficient radial force to provide continuous radial expansion as the thrombus is lysed;
does not comprise a backbone; and
is not a rolled mesh scaffold that is configured to overlap on itself.
25. The expandable tip assembly of claim 1 , wherein the scaffold comprises one or more of the following features:
a body having a triangular, elliptical, spiral or undulating configuration;
a non-thrombogenic coating or a coating with an anti-clotting drug;
a ratio of strut thickness to strut width is less than at least about 1.4;
parallelogram-shaped cells; and
U-shaped bridges between cells of the scaffold.